Envestnet Asset Management Inc Aspira Women'S Health Inc. Transaction History

Envestnet Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.32 - $0.58 $5,487 - $9,945	17,147 New	17,147 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.38 - $1.07 $2 - $6	6 Added 0.05%	11,334 $4,000
Q2 2022 Aug 03, 2022	SELL	$0.4 - $1.09 $29 - $79	-73 Reduced 0.64%	11,328 $7,000
Q1 2022 May 04, 2022	SELL	$0.88 - $1.81 $1,936 - $3,982	-2,200 Reduced 16.18%	11,401 $12,000
Q4 2021 Feb 04, 2022	BUY	$1.63 - $3.43 $5,613 - $11,812	3,444 Added 33.91%	13,601 $24,000
Q3 2021 Oct 07, 2021	BUY	$3.19 - $5.48 $32,400 - $55,660	10,157 New	10,157 $33,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.